The NIH is enrolling volunteers in an early-stage trial for an mRNA-based universal flu vaccine

The National Institutes of Health is now enrolling participants to test an experimental universal influenza vaccine using mRNA technology.The NIH is looking for 50 volunteers ages 18 to 49 for the Phase 1 trial at Duke University in Durham, North Carolina.A universal influenza vaccine would be a major public health achievement and could eliminate the need for both annual development of seasonal influenza vaccines, as well as the need for patients to get a flu shot each year, said Acting NIAID Director Dr. Hugh Auchincloss in a news release.

Read at www.cnn.com